Delivery Order SPE2DB24D2205-SPE2DB25FEGHP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,385.52 with firm fixed pricing and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order, leveraging the company's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, valued at $4,156.56 under a firm fixed-price contract structure. This delivery order is classified as non-set-aside and competitively awarded, with an ultimate completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52 with completion scheduled for September 23, 2025, represents a non-competitive award issued under an existing contract vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract is valued at $4,156.56 with a firm fixed-price structure and an ultimate completion date of September 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order, demonstrating the...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,385.52 and is structured as a firm fixed price delivery order with an ultimate completion date of September 26, 2025. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,385.52 to supply Orgovyx 120 mg tablets (30-count units) with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract features firm fixed-price pricing and reflects the DLA's ongoing pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGHPDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 per unit, with a ceiling value of $8,313.12 and an ultimate completion date of September 8, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting military and federal healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle valued through December 2026. The IDC enables the contractor to supply an extensive range of pharmaceuticals, medical devices, and specialty medications to support military healthcare programs globally. The award demonstrates the contractor's competitive capability in fulfilling federal medical procurement requirements and reflects the Defense Logistics Agency's pharmaceutical acquisition strategy through established prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 8/15/25 |